Medical Cannabis Bills GA23- SB 47, HB 22, SB 51, and SB 78
KY SB47 - AN ACT relating to medicinal cannabis.
Introduced Session 2023 Regular Session
Bill Summary
Create new sections of KRS Chapter 218A to define terms and establish a medicinal cannabis program; amend KRS 342.815 to establish that the Employer’s Mutual Insurance Authority shall not be required to provide coverage to an employer if doing so would subject the authority to a violation of state or federal law; amend KRS 216B.402 to require hospital emergency departments to report cases of cannabinoid hyperemesis syndrome to the Department of Alcoholic Beverage and Cannabis Control; amend KRS 218A.010, 218A.1421, 218A.1422, 218A.1423, and 218A.500 to conform; amend KRS 12.020, 12.252, 15.300, 15.380, 15.398, 15.420, 15A.340, 61.592, 62.160, 131.1815, 211.285, 241.010, 241.015, 241.030, 243.025, 243.0307, 243.038, 243.090, 243.360, 438.310, 438.311, 438.313, 438.315, 438.317, 438.320, 438.325, 438.330, 438.337, and 438.340 to change the name of the Department of Alcoholic Beverage Control to the Department of Alcoholic Beverage and Cannabis Control; some sections EFFECTIVE July 1, 2024.
Sponsors (12)
Stephen West (R)*, Shelley Frommeyer (R), Denise Harper Angel (D), Jimmy Higdon (R), Stephen Meredith (R), Gerald Neal (D), Mike Nemes (R), Brandon Smith (R), Reginald Thomas (D), Robin Webb (D), Phillip Wheeler (R), David Yates (D),
Last Action
to Committee on Committees (S) (on 01/05/2023)
Kentucky Senate Bill 47 is seen as a continuation of the previous discussions around medical cannabis as proposed by Rep. Nemes in previous legislative sessions. Although it has some flaws, such as the absence of home grows for patients and caregivers, no employment protections for medical cannabis patients, and the mandated use of pharmacists in dispensaries, these issues are not insurmountable.
SB 47 aims to promote a healthy medical cannabis industry while keeping a tight leash on qualifying patients. It has been supported by legislators from both sides of the aisle, as well as civil rights, law enforcement, union, veteran, medical organizations, and patient advocacy groups. However, SB 47 still needs support from more legislators to pass in the Senate.
Recently, we attended meetings with members of Senate leadership and committee chairpersons seeking support for the bill. We provided them with fact sheets on cannabis and the book on the Clinical Applications of Cannabis and Cannabinoids authored by Paul Armentano, Deputy Director of the National Organization for the Reform of Marijuana Laws, and Chair of Science at Oaksterdam University. Kentucky NORML offered to answer any questions they may have on the subject, but we have yet to hear back from anyone on that front.
We urge everyone to reach out to their legislators and ask them to support cannabis policy reform during this session. The clock is ticking, and we need more enthusiasm from legislators to support this bill and other proposed medical cannabis bills such as HB 22, HB 107, SB 51, and SB 78.
Let's make sure Kentucky moves forward in supporting safe and accessible medical cannabis for those who need it.
